Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus



Status:Completed
Conditions:Lupus
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - 70
Updated:4/21/2016
Start Date:July 2014
End Date:November 2015

Use our guide to learn which trials are right for you!

A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus

A one month multi-dose study will evaluate the safety and tolerability of 3 intravenous
infusions of RSLV-132 in subjects with inactive to mild SLE.


Inclusion Criteria:

- Stable SLE with no anticipated change in medications for the next 60 days

Exclusion Criteria:

- Other biologic drugs
We found this trial at
4
sites
2147 Northeast Coachman Road
Clearwater, Florida 33765
1102
mi
from
Clearwater, FL
Click here to add this to my saved trials
Dallas, Texas 75231
348
mi
from
Dallas, TX
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
1053
mi
from
Duncansville, PA
Click here to add this to my saved trials
Grand Rapids, Michigan 49546
739
mi
from
Grand Rapids, MI
Click here to add this to my saved trials